AGA Family of Websites:

Submit your microbiome research to DDW® 2019 by Dec. 1

Review the abstract descriptors and submit your research.

The AGA Institute Council Microbiome & Microbial Diseases in the Gastrointestinal Tract (MMDGT) Section has put out its annual call for novel microbiome research for Digestive Disease Week® (DDW). Help the MMDGT section in developing a strong microbiome program at DDW by submitting your research for consideration by Saturday, Dec. 1, 2018. More information and resources about abstract submission are available at

This year the section has developed the following abstract descriptors for you to submit your research to. These descriptors are intended to establish a deep understanding of interactions between microbiome communities and their hosts and will also provide new insight into how host and epigenetic factors influence gastrointestinal ecosystems. Many of these are also co-sponsored by other council sections. For a more detailed explanation of what should be presented, please see AGA’s Expanded Descriptors.

    • Clostridioides Difficile Colitis: Pathogenesis, Diagnosis, Management and Therapy
    • Diarrheal Diseases, Bacterial Overgrowth, Drug Induced and Other Enteropathies
    • Diet and the Gut Microbiome
    • Enteric Sensation in health and disease (Including Visceral Pain, Neuroimmunology, Epithelial Junctions, Intestinal Barrier Function/Dysfunction and Interactions with the Microbiome)
    • Extraintestinal Interactions of the Gut Microbiome
    • Food Intolerances, Allergy, and Sensitivities
    • IBD: Microbiome
    • Intestinal Inflammation, Fibrosis and Regeneration
    • Metabolism, Obesity, Microbiome, and Nutrition in GI Cancer Pathogenesis
    • Microbial Dysbiosis: Causes and Consequences
    • Microbial Pathogens and Toxins of the Intestine and Colon
    • Microbial Regulation of Host Metabolic and Energy Homeostasis
    • Microbial-Based Therapy
    • Microbial-induced Mucosal Inflammation and Innate Immunity
    • Microbiome and Cancer
    • Microbiome and Infectious Diseases
    • Non-Alcoholic Fatty Liver Diseases and NASH
    • Pediatric Microbiome and Microbial Therapies
    • Prebiotics, Probiotics and Synbiotics in Health and Disease
    • Role of the Gut Microbiome in Immune and Inflammatory Diseases
    • The Gastrointestinal Microbiome: Determinants and Dynamics of Structure and Function
    • The Microbiome in Pancreatitis, Pancreatic Malabsorption and Pancreatic Tumorigenesis
    • The Microbiome-Gut-Brain Axis in Health and Disease
    • Viral, Eukaryote, and Prokaryote Members of the Gut Microbiome

The goal of the AGA Institute Council MMDGT Section is to promote ideas, research, technology, education and dialogue that advance the understanding of the gastrointestinal microbiome in health and disease. The section achieves this goal by soliciting, reviewing and programing the majority of AGA’s microbiome related abstracts and content at DDW annually.

AGA clinical guidance

Find the latest evidence-based recommendations for treating your patients.